EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas.
DuCote TJ, Song X, Naughton KJ, Chen F, Plaugher DR, Childress AR, Gellert AR, Skaggs EM, Qu X, Liu J, Liu J, Li F, Wong KK, Brainson CF.
DuCote TJ, et al. Among authors: li f.
Cancer Res Commun. 2024 Feb 13;4(2):388-403. doi: 10.1158/2767-9764.CRC-23-0399.
Cancer Res Commun. 2024.
PMID: 38265267
Free PMC article.